Archives
Bradykinin (BA5201): Practical Use in Vascular Permeability
2026-06-25
Bradykinin (SKU BA5201) offers researchers a defined, endothelium-dependent vasodilator for controlled modeling of vascular permeability, smooth muscle contraction, and inflammation signaling. This product is best suited for in vitro or ex vivo workflows that demand precise peptide dosing and rapid solution handling. It should not be used for diagnostic or human/animal therapeutic applications.
Saquinavir: Applied HIV Protease Inhibitor Workflows & Optim
2026-06-25
Saquinavir stands out as a precision HIV protease inhibitor for both antiretroviral drug research and emerging applications in cancer biology. This article breaks down practical assay workflows, bridges the latest chromatographic insights to experimental design, and delivers actionable troubleshooting strategies for maximizing reproducibility with APExBIO’s Saquinavir.
Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding
2026-06-24
This study demonstrates that naturally occurring angiotensin peptides, including N-terminal fragments, significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings provide new mechanistic insight into the intersection of renin-angiotensin signaling and viral pathogenesis, with potential implications for COVID-19 research and therapeutic targeting.
Hydroxycinnamic Acids Inhibit cGAS-STING via COPII Cargo Sor
2026-06-23
This study reveals that hydroxycinnamic acids (HCAs) directly target the COPII Sec24 B-site, competitively blocking STING trafficking and suppressing downstream inflammatory signaling via the cGAS-STING axis. These findings establish a precise molecular basis for the anti-inflammatory and metabolic benefits of HCA-rich traditional medicines, with implications for novel therapeutic strategies in metabolic and autoinflammatory disorders.
PTGER4 Signaling Modulates HDAC Activity and SPINK4 in Recta
2026-06-23
Anbazhagan et al. provide mechanistic evidence that PTGER4 signaling, activated by PGE2 from mesenchymal stromal cells, regulates class IIa HDAC phosphorylation and SPINK4 mRNA levels in rectal epithelial cells. These findings clarify a pathway linking inflammatory signaling to epithelial gene regulation, with implications for mucosal healing and disease.
Prestained Protein Marker (Triple Color): Benchmarks & Appli
2026-06-22
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides robust, visually distinct molecular weight standards for SDS-PAGE and Western blotting. Its EDTA-free formulation ensures compatibility with advanced electrophoretic techniques, supporting reproducible protein size verification across multiple workflows.
EZH2 Inhibition Modulates Senescence and SASP via cGAS-STING
2026-06-22
This study reveals that inhibiting EZH2 can suppress the senescence-associated secretory phenotype (SASP) induced by the HDAC inhibitor SAHA in small cell lung cancer (SCLC) cells. The research uncovers a mechanistic link between chemotherapy-induced cytoplasmic chromatin fragments, activation of the cGAS-STING signaling pathway, and exacerbation of SASP, highlighting a potential combinatorial therapeutic approach for SCLC.
Uridine, Trisodium Salt: Optimizing RNA-Mediated Genome Engi
2026-06-21
Uridine, Trisodium Salt empowers precision RNA biosynthesis and innovative genome engineering, including PRINT-driven transgene insertion. High purity, robust solubility, and reproducible performance make it the reagent of choice for advancing safe, scalable gene therapy research.
Fosinopril Sodium in Translational Hypertension Research: Me
2026-06-20
Fosinopril sodium, a potent ACE inhibitor, offers distinct advantages in hypertension research through its unique dual elimination and mechanistic profile. This deep-dive article explores protocol design, mechanistic nuance, and practical assay decisions, filling scientific gaps left by existing resources.
Carvedilol Phosphate in Ischemia–Reperfusion Injury Models
2026-06-19
Carvedilol Phosphate stands out as a non-selective beta blocker optimized for cardiovascular and hepatic ischemia–reperfusion injury (IRI) research. Its unique solubility and purity enable reproducible protocols while recent mechanistic studies reveal new assay strategies for dissecting macrophage polarization. APExBIO’s offering empowers translational workflows, bridging molecular signaling with functional outcomes.
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-06-19
Wang et al. identify the METTL16-SENP3-LTF signaling axis as a key mechanism conferring ferroptosis resistance and promoting tumorigenesis in hepatocellular carcinoma. Their findings reveal a previously uncharacterized regulatory network involving m6A RNA modification, iron metabolism, and cell death susceptibility, with direct implications for therapeutic targeting in HCC.
β-Amanitin for Transcriptional Regulation: Protocols & Innov
2026-06-18
β-Amanitin is a gold-standard inhibitor for RNA polymerase II, uniquely enabling precise interrogation of mRNA synthesis and transcriptional regulation. This article delivers actionable protocols, troubleshooting guidance, and highlights the latest advances in dual toxin detection, all powered by APExBIO’s research-grade β-Amanitin.
Exo1 (SKU B6876): Precision Inhibition in Exocytosis Assays
2026-06-18
This article provides an evidence-based, scenario-driven guide for deploying Exo1 (SKU B6876), a methyl 2-(4-fluorobenzamido)benzoate-based inhibitor, in exocytosis and membrane trafficking research. We address real-world challenges faced by cell biologists, explore Exo1’s unique mechanistic advantages, and offer practical protocol recommendations—optimizing reproducibility and experimental clarity for biomedical researchers.
BAY-826: Potent Small Molecule Inhibitor for Retinal Researc
2026-06-17
BAY-826 is reshaping experimental workflows for retinal neuron survival studies by enabling precise control of angiopoietin and PEDF signaling. Its high potency and selectivity make it the inhibitor of choice for dissecting neurovascular mechanisms in cellular and co-culture models.
Angiotensin 1/2 (2-7) Peptide: Advanced Workflows & Assay Pr
2026-06-17
Angiotensin 1/2 (2-7) unlocks high-fidelity modeling of the renin-angiotensin system in cardiovascular and infectious disease research. This article details protocol enhancements, troubleshooting strategies, and cross-domain applications, helping researchers leverage this peptide’s unique mechanistic value.
605 records 17/41 page Previous Next First page 上5页 1617181920 下5页 Last page